Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

NCT00449163 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Study terminated by University of Miami Institutional Review Board

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Floxuridine
DRUG: Irinotecan
DRUG: Leucovorin

Sponsor

University of Miami